---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-064732"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:22:22.481628+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Oramed shareholders re-elect all seven directors, approve say-on-pay, ratify auditor at 2024 annual meeting

## Summary
- All seven director nominees re-elected with majority votes; top vote-getter Benjamin Shapiro had 10,120,322 for.
- Advisory vote on executive compensation passed: 9,171,779 for, 1,016,334 against.
- Ratification of Kesselman & Kesselman (PwC Israel) as FY 2024 auditor approved: 17,323,361 for.
- Broker non-votes of 7,236,740 on director elections and say-on-pay due to lack of discretionary voting.

## SEC filing metadata
- accession: 0001213900-24-064732
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024064732/0001213900-24-064732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024064732/ea0210492-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-064732
- JSON: https://secwatch.observer/filing/0001213900-24-064732.json
- Plain text: https://secwatch.observer/filing/0001213900-24-064732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.